Aspira Pathlab & Diagnostics share news and announcements

BSE: 540788Healthcare ServicesSmall Cap

₹126.05₹2.60 (2.11%)

Share price at the BSE close on 23 Oct 2026. Previous close ₹123.45.

52-week range of traded prices to 23 Oct 2026

₹49.00Low, 15 Apr 2026₹149.99High, 30 Sep 2026

Market cap: ₹130 Cr3,082nd largest listed
P/E: Lossover the last 12 months
P/B: 10.6
Dividend yield: Nonein the last 12 months
ROE: −3.7%
ROCE: −4.4%
Debt to equity: 0.11
Volume, BSE: 352

Aspira Pathlab & Diagnostics share news and announcements

520 announcements, routine notices left out, newest first. Page 10 of 11.

Jan 2019
- 21 Jan · Results
  We hereby inform you that the Board of Directors of the Company, at its meeting held today i.e. Monday, January 21, 2019 inter alia considered and approved the unaudited Standalone financial .... (opens in a new tab)
- 21 Jan · Results
  In accordance with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (read with Part A of schedule III), We hereby inform you that the .... (opens in a new tab)
- 12 Jan · Revision of Board Meeting
  Purpose of the meeting has been revised (opens in a new tab)
- 12 Jan · Board meeting
  Meeting of the Board of Directors of the Company is scheduled on 21/01/2019 ,inter alia, to consider and approve We wish to inform .... (opens in a new tab)
- 10 Jan · Statement Of Investor Complaints For The Quarter Ended December 2018
  No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0 0 0 0
- 8 Jan · Shareholding for the Period Ended December 31, 2018
  Shareholding Pattern for the Period Ended December 31, 2018. For more details, kindly Click ....
Oct 2018
- 27 Oct · Management
  Appointment of Dr. Haseeb Drabu as additional Independent Director (opens in a new tab)
- 27 Oct · Management
  Resignation of Dr. Paresh Bhanushali (opens in a new tab)
- 27 Oct · Results
  Submission of Financial Results for 30th September , 2018 (opens in a new tab)
- 27 Oct · Board meeting
  In accordance with Regulation 30 of SEBI LODR Regulations, 2015, we hereby inform you that board has appoved financial results for the quarter and half year ended 30th September, 2018. (opens in a new tab)
- 25 Oct · Compliance Certificate For The Half Year Ended 30Th September, 2018
  We are enclosing herewith Compliance certificate under Regulation 7(3) of SEBI Listing Obligation & Disclosure Regulations, 2015 for the half year ended 30th September, 2018. (opens in a new tab)
- 24 Oct · Compliances Under Regulation 40(9) And 40(10) Of SEBI (LODR) Reguations, 2015.
  We send herewith a certificate for half-year ended September 30, 2018, duly signed by Mr. S.K. Pandey, Practicing Company Secretaries, pursuant to the provisions under Regulation 40(9) .... (opens in a new tab)
- 20 Oct · Shareholding for the Period Ended September 30, 2018
  Shareholding Pattern for the Period Ended September 30, 2018. For more details, kindly Click ....
- 19 Oct · Board meeting
  Meeting of the Board of Directors of the Company is scheduled on 27/10/2018 ,inter alia, to consider and approve the unaudited financial results .... (opens in a new tab)
- 19 Oct · Statement Of Investor Complaints For The Quarter Ended September 2018
  No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0 0 0 0
- 15 Oct · Announcement under Regulation 30 (LODR)-Public Announcement-Delisting
  This is to inform you that the Company has got Voluntary Delisting approval from the Calcutta Stock Exchange Limited ('CSE') w.e.f 15th October, 2018 as per the notice received from CSE .... (opens in a new tab)
- 1 Oct · Results
  Details of Voting results of AGM, under Regulation 44(3) of SEBI (LODR) Regulations, 2015. Kindly ....
Sep 2018
- 29 Sep · Meeting
  We wish to inform you that the 45th Annual General Meeting (AGM) of the Company was held on Saturday, September 29, 2018 at 608-611, Marathon Max, Mulund Goregaon Link Road, Mulund (W), .... (opens in a new tab)
- 29 Sep · Meeting
  Summary of Proceedings of the 45th Annual General Meeting held on September 29, 2018 In accordance with the Regulations 30(6) of the SEBI (Listing Obligations and Disclosure Requirements) .... (opens in a new tab)
- 17 Sep · Disclosure
  Exchange has received the revised disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Vinod Bhanushali HUF (opens in a new tab)
- 5 Sep · Closure Of Register Of Members And Share Transfer Book
  We wish to inform you that the register of members and share transfer book of the company will be closed from Thursday, September 27, 2018 to Saturday, September 29, 2018 (both days inclusive) .... (opens in a new tab)
- 5 Sep · Meeting
  This is to inform you that the 45th Annual General Meeting of the members of the Company will be held on Saturday, 29th September, 2018 at 11.00 a.m. at 608, Marathon Max, Mulund Goregaon .... (opens in a new tab)
- 4 Sep · Shareholding for the Period Ended August 24, 2018
  Shareholding Pattern for the Period Ended August 24, 2018. For more details, kindly Click ....
- 1 Sep · Business
  We would like to inform you that the Company has executed a Business Transfer Agreement and other related documents ('Agreement') with M/s. Om Diagnostics Lab Private Limited ('Om Diagnostics') .... (opens in a new tab)
Aug 2018
- 30 Aug · Disclosure
  Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Paresh Bhanushali (opens in a new tab)
- 30 Aug · Disclosure
  Exchange has received the disclosure under Regulation 29(1) & 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Geeta Bhanushali, Vinod Bhanushali .... (opens in a new tab)
- 30 Aug · Disclosure
  Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Rinku Bhanushali (opens in a new tab)
- 30 Aug · Disclosure
  Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Vinod Bhanushali (opens in a new tab)
- 30 Aug · Disclosure
  Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Vinod Bhanushali HUF (opens in a new tab)
- 30 Aug · Disclosure
  Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Yash Raj Biotechnology Ltd (opens in a new tab)
- 29 Aug · Disclosure
  Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Geeta Bhanushali (opens in a new tab)
- 29 Aug · Disclosure
  Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Arvind Bhanushali & Deepali Bhanushali (opens in a new tab)
- 24 Aug · Board meeting
  Outcome of Operation committee Meeting of Board Of Directors. The Operation committee of Directors of the Company at its meeting held on August24,2018 at 12PM has approved .... (opens in a new tab)
- 13 Aug · Results
  Please find attached Financial Results for the quarter ended June 30, 2018 (opens in a new tab)
- 11 Aug · Board meeting
  We wish to inform you that the Board of Directors of the Company at their meeting held on Saturday, 11th August, 2018 has discussed and approved the Unaudited financial results along .... (opens in a new tab)
- 10 Aug · Announcement under Regulation 30 (LODR)-Change in RTA
  Intimation of Tripartite Agreement Entered Between the Old Registrar and Share Transfer Agent, The New Registrar and Share Transfer Agent and The Company. As per Regulation 7 (5) .... (opens in a new tab)
- 4 Aug · Board meeting
  Meeting of the Board of Directors of the Company is scheduled on 11/08/2018 ,inter alias, to consider and approve We wish to inform you that, pursuant .... (opens in a new tab)
- 1 Aug · Results
  Details of Voting results of EGM, under Regulation 44(3) of SEBI (LODR) Regulations, 2015. Kindly ....
- 1 Aug · Meeting
  We wish to inform you that the Extra Ordinary General Meeting (EGM) of the Company was held on Tuesday, July 31, 2018 at 608-611, Marathon Max, Mulund Goregaon Link Road, Mulund (W), Mumbai- 400080. .... (opens in a new tab)
Jul 2018
- 31 Jul · Meeting
  In accordance with the Regulations 30(6) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, read with Part A of schedule III, to the Regulations, please find .... (opens in a new tab)
- 21 Jul · Meeting
  This is with reference to Extra Ordinary General Meeting (EGM) Notice dated June 29, 2018 seeking approval of the shareholders of the Company at the EGM to be held on July 31, 2018, for .... (opens in a new tab)
- 18 Jul · Shareholding for the Period Ended June 30, 2018
  Shareholding Pattern for the Period Ended June 30, 2018. For more details, kindly Click ....
- 18 Jul · Statement Of Investor Complaints For The Quarter Ended June 2018
  No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0 0 0 0
- 6 Jul · Meeting
  In continuation to our letter dated 29th June 2018 submitted with you, please find enclosed a copy of the Notice of the Extra Ordinary General Meeting ('EGM') scheduled to be held on .... (opens in a new tab)
Jun 2018
- 29 Jun · Meeting
  With reference to our letter dated May 17, 2018, Aspira Pathlab & Diagnostics Limited (Formerly known as Utkal Soap Products Limited) is now propose to hold the Extra Ordinary General Meeting .... (opens in a new tab)
May 2018
Apr 2018
- 24 Apr · Certificate Under Regulation 40(10) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
  Please find attached certificate under Regulation 40(10) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (opens in a new tab)

Aspira Pathlab & Diagnostics share news and announcements

Jan 2019

Oct 2018

Sep 2018

Aug 2018

Jul 2018

Jun 2018

May 2018

Apr 2018